In contrast, the loss of PTEN in non‐tumor‐forming β‐cells leads to the down‐regulation of P16ink4a expression, and this effect partially blocks the aging‐related loss of cell proliferation capacity (Zeng et al., 2013). This evidence concerns the gene CDKN2A and neoplasm.